top of page
  • White Facebook Icon
  • White Twitter Icon

M&A Transaction

Updated: Sep 19, 2024

Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A. (Greece) on its sale to Rosemont Pharmaceuticals Ltd. (United Kingdom).


Pharma-Data specialises in Research and Development and development of Value-Added Medicinal Drug Products for Europe and USA. Rosemont is a leading developer, manufacturer and distributor of liquid medicines for over 50 years.


The acquisition complements Rosemont’s product development capability in house as well as improving Rosemont’s capability to develop other dosage forms and modified release oral liquids.


 
 
 

Recent Posts

See All
M&A Transaction

Scope Law advises Jung von Matt IMPACT AG , Zurich, on its strategic participation in the Generation Media AG , Zurich. Jung von Matt...

 
 
 
Financing Round

Scope Law advises ETFbook , Zurich, in its EUR 4 million Series A financing round, led by BlackFin Capital Partners BlackFin Capital...

 
 
 
Financinground

Scope Law advises qCella AG , Zurich, a spin-off of ETH Zurich in its CHF 1.3 million pre-seed financing round. Participating investors...

 
 
 

Comments


bottom of page